Showing results (41-50 of 70) with videos related to
Sort By:
Pageof 7
Genome Announcements|April 16, 2016
Draft Genome Sequences of 11 Clinical Isolates of Acinetobacter baumanniiP G Higgins, J Z-M Chan, H Seifert, et al.Thrombosis Research|February 15, 1989
von Willebrand factor is an acute phase reactant in manB E Pottinger, R C Read, E M Paleolog, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 19, 2008
Molecular epidemiology of clinical Acinetobacter baumannii and Acinetobacter genomic species 13TU isolates using a multilocus sequencing typing schemeH Wisplinghoff, C Hippler, S G Bartual, et al.The Journal of Antimicrobial Chemotherapy|December 1, 1987
Intranasal chalcone, Ro 09-0410, as prophylaxis against rhinovirus infection in human volunteersW Al-Nakib, P G Higgins, I Barrow, et al.Journal of Interferon Research|January 1, 1983
Comparative intranasal pharmacokinetics of interferon using two spray systemsH W Davies, G M Scott, J A Robinson, et al.Archives of Virology|January 1, 1987
Failure of intranasally administered 4', 6-dichloroflavan to protect against rhinovirus infection in manW Al-Nakib, J Willman, P G Higgins, et al.Antiviral Research|August 1, 1983
An effective dosage regimen for prophylaxis against rhinovirus infection by intranasal administration of HuIFN-alpha 2R J Phillpotts, G M Scott, P G Higgins, et al.Antimicrobial Agents and Chemotherapy|May 1, 1985
Studies on 44 081 R.P., a new antirhinovirus compound, in cell cultures and in volunteersA Zerial, G H Werner, R J Phillpotts, et al.Antimicrobial Agents and Chemotherapy|November 1, 1983
Intranasal interferon as protection against experimental respiratory coronavirus infection in volunteersP G Higgins, R J Phillpotts, G M Scott, et al.Acta Oto-Laryngologica|March 1, 1989
Changes in human nasal mucosa during experimental coronavirus common coldsM Bende, I Barrow, J Heptonstall, et al.Pageof 7